| Name | Title | Contact Details |
|---|
Profusa, Inc. is leading the development of a new generation of biologically integrated sensors that empowers an individual with the ability to continuously monitor their unique body chemistry in unprecedented ways to transform the management of personal health and disease. Overcoming the bodys response to foreign material, the companys technology enables the development of minute bioengineered sensors that become one with the body to detect and transmit clinical-grade data for personal and medical use.
Health Care System Consultants is a Milwaukee, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
United States-Mexico Border Health Commission is a El Paso, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Pulmonx is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
In 2015, five seminal randomized controlled trials were published in the neurovascular space demonstrating endovascular thrombectomy to be the new gold standard for treating large vessel occlusion strokes. During that same year, advancements in artificial intelligence and deep learning made it possible to analyze medical imaging rapidly and accurately. However, despite having proven effective interventions for stroke, most stroke patients were getting treatment late or not at all. At Stanford University, Dr. Chris Mansi (neurosurgeon) and Dr. David Golan (machine learning researcher) identified this problem and together they sought to change it.